Amgen CEO's retirement pay could register at $49M

Stock options and deferred compensation have built up a comfortable $49 million nest egg for retiring Amgen ($AMGN) CEO Kevin Sharer. Dow Jones reports, though, that Sharer's 2011 compensation slipped 11% to $18.9 million. Robert Bradway (photo), who is taking the helm at the world's biggest biotech, nabbed $7.1 million in compensation for 2011, also down from 2010. He's getting a $1.4 million salary for the new job. Story


Suggested Articles

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.

Gilead presented studies at AASLD showing how noninvasive testing and machine learning could improve diagnostics and drug development for NASH.